Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
A FakhriRavari, S Jin, FH Kachouei… - International Journal …, 2021 - journals.sagepub.com
The underlying cause of many complications associated with severe COVID-19 is attributed
to the inflammatory cytokine storm that leads to acute respiratory distress syndrome (ARDS) …
to the inflammatory cytokine storm that leads to acute respiratory distress syndrome (ARDS) …
Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease
SA Fatima, M Asif, KA Khan, N Siddique… - Annals of Medicine …, 2020 - journals.lww.com
Background: The first case of Infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) were diagnosed in Wuhan, China in 2019. In the first half of 2020 this …
(SARS-CoV-2) were diagnosed in Wuhan, China in 2019. In the first half of 2020 this …
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
Use of corticosteroids in coronavirus disease 2019 pneumonia: a systematic review of the literature
The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-
19. A systematic search of the literature across nine databases was conducted from …
19. A systematic search of the literature across nine databases was conducted from …
The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis
J Wang, W Yang, P Chen, J Guo, R Liu, P Wen, K Li… - PloS one, 2021 - journals.plos.org
Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …
Comparison of associations between glucocorticoids treatment and mortality in COVID-19 patients and SARS patients: a systematic review and meta-analysis
J Li, X Liao, Y Zhou, L Wang, H Yang, W Zhang… - Shock, 2021 - journals.lww.com
Background: The response to glucocorticoids treatment may be different between
coronavirus disease 2019 (Covid-19) and severe acute respiratory syndrome (SARS) …
coronavirus disease 2019 (Covid-19) and severe acute respiratory syndrome (SARS) …
Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials
R Raju, PV, PS Biatris - Future journal of pharmaceutical sciences, 2021 - Springer
Abstract Background In March 2020, the World Health Organization declared the
coronavirus disease 2019 as a global pandemic. Though antiviral drugs and antimalarial …
coronavirus disease 2019 as a global pandemic. Though antiviral drugs and antimalarial …
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID‐19)
Objectives To assess the efficacy of corticosteroid treatment of patients with coronavirus
disease 2019 (COVID‐19). Design, setting Observational study in the two COVID‐19 …
disease 2019 (COVID‐19). Design, setting Observational study in the two COVID‐19 …
Corticosteroids for COVID-19 ✩
D Annane - Journal of Intensive Medicine, 2021 - mednexus.org
Coronavirus disease 19 (COVID-19) is placing a major burden on healthcare, economy and
social systems worldwide owing to its fast spread and unacceptably high death toll. The …
social systems worldwide owing to its fast spread and unacceptably high death toll. The …
COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency
The current Coronavirus disease outbreak requires that physicians work in collaboration
with other physicians especially in intensive care and emergency units. To fight against this …
with other physicians especially in intensive care and emergency units. To fight against this …